DPP - 4抑制剂有很多作用，但其中之一是抑制食欲，还有刺激胰岛素的分泌。
DPP-4 inhibitors do many things but one of them is to suppress appetite and another is to stimulate insulin secretion.
寻找PTP1B的特异性抑制剂，通过抑制PTP1B的活性来提高胰岛素信号通路的敏感性，对糖尿病和肥胖症治疗有着重要的应用前景。
Inhibition of PTP1B's activity could improve the sensitivity of insulin signaling. The discovery of highly effective inhibitors of PTP1B has a promising application in diabetes and obesity therapy.
有的医院，医生已经试着将DPP - 4抑制剂与胰岛素联合使用。
In some hospitals, the doctors have tried to use the DPP-4 inhibitor combined with insulin.
二甲双胍和吡格列酮都是胰岛素增敏剂，因此这两类药物不会导致低血糖，而GLP-1类似物或DPP-IV抑制剂导致低血糖的概率也很低。
The metformin and pioglitazone are insulin sensitizers so they never lower you blood glucose below normal and the GLP-1 analogues or DPP-IV inhibitors also never lower your blood glucose below normal.
胰岛素受体自身酪氨酸磷酸化抑制剂一一HNMPA一AM3可以阻断胰岛素的抗凋亡作用。
HNMPA-AM3 -the insulin receptor tyrosine kinase inhibitor could block the anti-apoptosis effect of insulin.
安全助疗效，钠葡萄糖协同转运蛋白2抑制剂，如添加胰岛素在1型糖尿病患者。
Efficacy and Safety of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, as Add-On to Insulin in Patients With Type 1 Diabetes.
安全助疗效，钠葡萄糖协同转运蛋白2抑制剂，如添加胰岛素在1型糖尿病患者。
Efficacy and Safety of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, as Add-On to Insulin in Patients With Type 1 Diabetes.
应用推荐